Showing 1,421 - 1,440 results of 104,136 for search '(( e point decrease ) OR ( 5 ((((mean decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.59s Refine Results
  1. 1421
  2. 1422

    Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice. by Toshiyuki Fukada (156297)

    Published 2008
    “…Data represent mean±S.D. F. Collagen of corneal stroma is decreased in <i>Slc39a13</i>-KO mice. …”
  3. 1423
  4. 1424
  5. 1425

    Blocking TNF or IL-6 decreases HIV-1 replication significantly in a dose dependent manner. by Shahin Ranjbar (66979)

    Published 2013
    “…Blocking TNF (at 2 ug/ml or 5 ug/ml) or IL-6 (5 ug/ml) significantly decreased virus replication (*, p<0.05) as compared to the same concentrations of an IgG<sub>1</sub> control antibody. …”
  6. 1426
  7. 1427
  8. 1428
  9. 1429
  10. 1430
  11. 1431
  12. 1432
  13. 1433

    <i>Zip88E</i><sup><i>Δ/Δ</i></sup> larvae have decreased <i>MtnB</i>:<i>EYFP</i> expression. by Christopher D. Richards (4246669)

    Published 2017
    “…Band intensity for <i>Zip88E</i><sup><i>Δ/Δ</i></sup> larvae was calculated relative to controls and averaged over multiple western blots (values are represented as the mean ± SD, N ≥ 3). C) There is an approximate 5 fold decrease in <i>MtnB</i>:<i>EYFP</i> expression in <i>Zip88E</i><sup><i>Δ/Δ</i></sup> larvae compared to controls when raised on basal media. …”
  14. 1434
  15. 1435

    Data Sheet 1_Elevated relative humidity significantly decreases cannabinoid concentrations while delaying flowering development in Cannabis sativa L..docx by Ingrid Carolina Corredor-Perilla (22631510)

    Published 2025
    “…Furthermore, high RH significantly suppressed cannabinoid accumulation: cannabidiolic acid (CBD-A), cannabidiol (CBD), and cannabichromenic acid (CBC-A) levels decreased by approximately 4.9-fold, 3.2-fold, and 13-fold, respectively. …”
  16. 1436
  17. 1437

    Decreased self-renewal capacity associated with senescence was prevented in human MSCs following treatment with Ki16425, an LPA<sub>1</sub>/LPA<sub>3</sub> antagonist. by Masahiko Kanehira (183764)

    Published 2012
    “…Human MSCs at passage 2 were cultured in the presence or absence of Ki16425 for the indicated days prior to cell lysis. Fold-change represents decrease in band intensity of Ki16425 treatment for 18 days compared with a control treatment for the same period of time. …”
  18. 1438
  19. 1439
  20. 1440